Shanghai Huirui

Shanghai Huirui Biotechnology is a multifaceted life sciences company based in Shanghai, China, specializing in molecular diagnostics, research reagents, and pharmaceutical ingredients. The company develops and manufactures a broad portfolio of products, including high-performance qPCR master mixes, nucleic acid extraction kits, and diagnostic assays for infectious diseases such as H7N9 avian influenza and COVID-19. Additionally, through its chemical technology division, it serves as a supplier of high-purity active pharmaceutical ingredients (APIs) and peptides, including research-grade weight loss compounds like Retatrutide and Cagrilintide. Huirui supports a global customer base across clinical diagnostics, academic research, and pharmaceutical development with its expertise in probe-based detection and biochemical synthesis.